You may have noticed that TipRanks recently revamped its popular Analysts’ Top Stocks tool. The result: it’s even easier to find new investing ideas from top-performing analysts.
In essence, the tool selects stocks based on a TipRanks developed formula, factoring in ratings made by the best-performing analysts. These are the analysts that score the highest success rate and average return out of a pool of over 5,100 analysts tracked by our system.
Now this tool has had a refresh. Let’s dive in and see how you make the most of the new features to find the most compelling investing opportunities.
Pinpointing top stocks
First of all, select the relevant investment criteria:
Here we went for a ‘Strong Buy’ stock rating with any market cap, and from any sector. This ‘Strong Buy’ rating is based on all the top analyst ratings for the stock published over the last three months.
Using this criteria, and selecting all column options, brings up the following table:
As you can see the stocks are listed alphabetically. And as you can also see all the stocks have put on a fairly abysmal performance over the last three months.
With the tool redesign, we can now order the results by the relevant criteria. For example, if you want to find the stocks with the most upside potential according to the Best Analyst Price Target, simply click that column to bring those stocks to the top. (This measures the upside potential from the current share price to the average top analyst price target.)
Here we are interested in stocks that are rallying right now. So let’s click on the recent stock performance column and see what comes up. This is a screenshot of the first five stocks that appear:
All of the five stocks here have gained over 20% in the last three months. Plus they all score a ‘Strong Buy’ consensus from the Street. Scrolling through the stocks also reveals the picks with serious upside potential left to run. We can then click on the stock ticker for further analysis and insights into how financial experts are rating that stock right now.
Diving into APPS
Let’s take a closer look now at why tech stock Digital Turbine (APPS– Research Report) has just soared by 50%- and where analysts see this stock going next. APPS is a Mobile Delivery platform allowing people to discover new apps, for operators and OEMs to build new revenue streams, and for advertisers to reach users at scale.
On February 6 the stock received 3 buy ratings from top analysts:
The stock surged on the back of December earnings results that beat expectations. Revenues in the quarter were $30 million, up from $23 million in the year ago quarter. Gross margins continued their upward momentum for the third quarter in a row, while adjusted EBITDA came in at $3.8 million up from $1.6 million in the previous quarter.
Post-results, Ilya Grozovsky (Track Record & Ratings) of National Securities wrote: “We are maintaining our belief that the core product and new products have positioned the company with some of the best fundamentals in the technology sector.”
He continues: “As a result of these fundamentals, and given the shift to CY20 estimates for valuation purposes, we are raising our price target to $4.15 from $3.50.” This new price target indicates 70% upside potential from current levels.
And check out these other soaring stocks:
The other four top stocks found by the tool are:
eHealth, Inc. (EHTH– Research Report) – this company bills itself as America’s first and largest private online marketplace for health insurance. Following a ‘great’ Q4, shares surged, with five top analysts publishing EHTH buy ratings. Craig-Hallum’s George Sutton (Track Record & Ratings) ramped up his price target from $37 to $75, while Evercore ISI’s Ross Muken (Track Record & Ratings) initiated the stock with a ‘buy.’ He sees eHealth as uniquely positioned with a path to $1B in revenue over the next decade.
Zendesk Inc (ZEN– Research Report) – customer service software stock Zendesk is trading up over 30% in the last three months. ZEN just reported its highest revenue growth in two years, with revenue beating consensus by $6.6M on 41% top-line growth. “We are raising our PT to $92 from $71 based on the combination of higher estimates and a growth outlook that could justify further multiple expansion as the Company’s product portfolio and enterprise traction builds through 2019” cheered KeyBanc analyst Brent Bracelin (Track Record & Ratings) on February 5.
uniQure NV (QURE– Research Report) – biotech QURE uses gene therapy to transform the lives of patients. According to the Street, this is a stock that can double. The company has just announced that it has dosed the 1st patient in the pivotal phase III HOPE-B trial in hemophilia B. “We see today’s news as evidence that QURE is on track to report data from HOPE-B in 2H20, likely well ahead of Pfizer” states Chardan Capital’s Gbola Amusa (Track Record & Ratings). He reiterated his buy rating with a $70 price target (104% upside potential).
Proofpoint Inc (PFPT– Research Report) – cybersecurity stock Proofpoint has also just reported solid Q4 results, thanks to strong execution and improving sales productivity. “We view this quarter’s results as evidence of continued execution. With the addition of greater clarity around key issues we continue to believe PFPT deserves further rerating” says Evercore ISI’s Kenneth Talanian (Track Record & Ratings). As a result, this five-star analyst boosted his price target from $105 to $125. He now sees multiple levers ahead for PFPT to exceed 2019 estimates.
Enjoy the Research Report on the Stocks in this Article:
Digital Turbine Inc (APPS) Research Report
eHealth Inc (EHTH) Research Report
Proofpoint (PFPT) Research Report
uniQure NV (QURE) Research Report
The TipRanks database covers over 5,000 stocks from eight different sectors. Which stocks are the top-performing analysts recommending right now? Go to the Analysts’ Top Stocks Tool now
